Organon & Co.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $187.0M | $864.0M | $1.02B | $917.0M | $1.35B | $2.16B | $3.22B |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | $156.0M | $132.0M | $120.0M | $96.0M | $92.0M | $56.0M | $49.0M |
| Amortization | $205.0M | $145.0M | $116.0M | $116.0M | $103.0M | $86.0M | $284.0M |
| Stock-Based Compensation | $77.0M | $105.0M | $101.0M | $75.0M | $59.0M | $40.0M | $41.0M |
| Net Cash from Operating Activities | $700.0M | $939.0M | $799.0M | $858.0M | $2.16B | $2.28B | $3.02B |
| Investing Activities | |||||||
| Capital Expenditures | $162.0M | $175.0M | $251.0M | $196.0M | $192.0M | $255.0M | $92.0M |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-390.0M | $-513.0M | $-260.0M | $-420.0M | — | — | — |
| Financing Activities | |||||||
| Dividends Paid | $88.0M | $297.0M | $294.0M | $290.0M | $145.0M | $0 | $0 |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-561.0M | $-368.0M | $-569.0M | $-433.0M | — | — | — |
| Net Change in Cash | $-101.0M | $-18.0M | $-13.0M | $-31.0M | $667.0M | $-249.0M | $75.0M |
| Free Cash Flow | $538.0M | $764.0M | $548.0M | $662.0M | $1.97B | $2.03B | $2.93B |